NO975409L - <Delta>P62, varianter derav, nukleinsekvenser og deres anvendelse - Google Patents

<Delta>P62, varianter derav, nukleinsekvenser og deres anvendelse

Info

Publication number
NO975409L
NO975409L NO975409A NO975409A NO975409L NO 975409 L NO975409 L NO 975409L NO 975409 A NO975409 A NO 975409A NO 975409 A NO975409 A NO 975409A NO 975409 L NO975409 L NO 975409L
Authority
NO
Norway
Prior art keywords
depart
variants
nucleotide sequences
nucleotide
sequences
Prior art date
Application number
NO975409A
Other languages
English (en)
Norwegian (no)
Other versions
NO975409D0 (no
Inventor
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO975409D0 publication Critical patent/NO975409D0/no
Publication of NO975409L publication Critical patent/NO975409L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO975409A 1995-06-01 1997-11-25 <Delta>P62, varianter derav, nukleinsekvenser og deres anvendelse NO975409L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9506533A FR2734826B1 (fr) 1995-06-01 1995-06-01 Deltap62, ses variants, sequences nucleiques et leurs utilisations
PCT/FR1996/000802 WO1996038556A2 (fr) 1995-06-01 1996-05-29 Deltap62, ses variants, sequences d'acides nucleiques les codant, et leurs utilisations en therapie genique anti-cancereuse

Publications (2)

Publication Number Publication Date
NO975409D0 NO975409D0 (no) 1997-11-25
NO975409L true NO975409L (no) 1997-11-25

Family

ID=9479588

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975409A NO975409L (no) 1995-06-01 1997-11-25 <Delta>P62, varianter derav, nukleinsekvenser og deres anvendelse

Country Status (15)

Country Link
US (1) US6544948B1 (hu)
EP (1) EP0828832A2 (hu)
JP (1) JPH11506325A (hu)
KR (1) KR19990022193A (hu)
AU (1) AU718889B2 (hu)
BR (1) BR9608632A (hu)
CA (1) CA2219861A1 (hu)
CZ (1) CZ291533B6 (hu)
FR (1) FR2734826B1 (hu)
HU (1) HUP9901346A3 (hu)
IL (1) IL118493A0 (hu)
NO (1) NO975409L (hu)
SK (1) SK283071B6 (hu)
WO (1) WO1996038556A2 (hu)
ZA (1) ZA964392B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2493300A (en) * 1999-01-06 2000-07-24 Regents Of The University Of California, The Modulation of hiv replication using sam68
PT1414960E (pt) 2001-07-30 2008-04-28 G R M O Groupe De Rech En Mala Doença óssea de paget
JP6193231B2 (ja) * 2011-08-08 2017-09-06 チュアラボ オンコロジー, インコーポレーテッドCurelab Oncology, Inc. がんの治療および予防のための、ｐ６２に関する方法および組成物
WO2021231652A1 (en) * 2020-05-14 2021-11-18 Curelab Oncology, Inc. Using the p62 plasmid to treat or reduce the severity of coronavirus infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610276A (en) * 1991-05-17 1997-03-11 Chiron Corporation Polypeptides and antibodies derived from GAP associated protein, p62
KR100356615B1 (ko) * 1993-07-13 2003-04-03 아방티 파르마 소시에테 아노님 결함아데노바이러스벡터및유전자치료에서그의사용

Also Published As

Publication number Publication date
SK161397A3 (en) 1998-07-08
US6544948B1 (en) 2003-04-08
ZA964392B (en) 1996-12-09
FR2734826B1 (fr) 1997-07-04
WO1996038556A2 (fr) 1996-12-05
CA2219861A1 (fr) 1996-12-05
NO975409D0 (no) 1997-11-25
WO1996038556A3 (fr) 1997-01-09
MX9708877A (es) 1998-03-31
CZ291533B6 (cs) 2003-03-12
IL118493A0 (en) 1996-09-12
EP0828832A2 (fr) 1998-03-18
KR19990022193A (ko) 1999-03-25
HUP9901346A2 (hu) 1999-08-30
AU6129196A (en) 1996-12-18
SK283071B6 (sk) 2003-02-04
FR2734826A1 (fr) 1996-12-06
CZ375997A3 (cs) 1998-02-18
HUP9901346A3 (en) 2000-10-30
BR9608632A (pt) 1999-05-04
JPH11506325A (ja) 1999-06-08
AU718889B2 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
NO961160D0 (no) Cykliske forbindelser, deres fremstilling og anvendelse
DE69840172D1 (de) Rna exportelement
NO980720D0 (no) Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
NO975419L (no) Gen-svitsj omfattende en ecdysonreseptor
DE69632759D1 (de) Ostomiekupplung
DE69428043T2 (de) Pre-keramische silikon-polymere
DK1019358T4 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
DK0832104T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
FI964423A (fi) DNA-sekvenssit
BR1100839A (pt) Gene homebox de interrupção de crescimento
BR9401355A (pt) Oligonucleotídeo e nucleotídeo.
AU6244296A (en) Novel beta-xylosidase, nucleotide sequence encoding it, and use thereof
ID21013A (id) Deret nukleotida antipeka
DE69632758D1 (de) Ostomiekupplung
NO982701D0 (no) Polymerisasjonskatalysatorer og fremgangsmÕter derav
DE69606691D1 (de) Silikonhaltige Blockcopolymere
NO20005502D0 (no) Polymerer og deres anvendelse
ATE386058T1 (de) Polymerisationsverfahren
NO975409L (no) &lt;Delta&gt;P62, varianter derav, nukleinsekvenser og deres anvendelse
NO20003128D0 (no) Nye p-aminofenylderivater og deres anvendelse
IT242732Y1 (it) Attacco ortodontico
NO972973L (no) Renseanlegg
NO982242D0 (no) Heparinanaloge kopolymerer, deres fremstilling og anvendelse
KR970020683U (ko) 일체형 젖가락
DE29512219U1 (de) Keramisches Übergangsteil

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application